DEPOCYT Side Effects

6973512-4 | Haemorrhage, Headache, Papilloedema
on Aug 20, 2010 Male patient from AUSTRIA , 18 years of age, was diagnosed with acute myeloid leukaemia and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, headache (What is headache?), papilloedema. Depocyt dosage: 50 Mg;x 3; Inth.

6973058-3 | Back Pain, Cauda Equina Syndrome, Diplopia, Dysuria, Gastrointestinal Motility Disorder, Headache, Papilloma, Retinal Haemorrhage, Sepsis
Patient was taking Depocyt (View Usage). Patient had the following side effects: back pain (What is back pain?), cauda equina syndrome, diplopia, dysuria, gastrointestinal motility disorder, headache (What is headache?), papilloma, retinal haemorrhage, sepsis (What is sepsis?) on Aug 20, 2010 from AUSTRIA Additional patient health information: Male patient , 18 years of age, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and. Depocyt dosage: 50 Mg; X 4; Inth.

6973057-1 | Back Pain, Cauda Equina Syndrome, Diplopia, Neurotoxicity, Papilloedema, Radiculopathy, Swelling
Adverse event was reported on Aug 20, 2010 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg; X 3; Inth) was diagnosed with acute myeloid leukaemia and. Location: AUSTRIA , 13 years of age, weighting 125.7 lb, After Depocyt was administered, patient had the following side effects: back pain (What is back pain?), cauda equina syndrome, diplopia, neurotoxicity, papilloedema, radiculopathy, swelling.

6963820-5 | Arachnoiditis, Back Pain, Diplopia, Hyperacusis, Intracranial Pressure Increased, Nuchal Rigidity, Papilloedema, Paresis Cranial Nerve, Photophobia
on Aug 16, 2010 Male patient from BELGIUM , 27 years of age, was diagnosed with t-cell type acute leukaemia and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: arachnoiditis, back pain (What is back pain?), diplopia, hyperacusis, intracranial pressure increased, nuchal rigidity, papilloedema, paresis cranial nerve, photophobia. Depocyt dosage: . Patient was hospitalized.


6963819-9 | Csf Pressure Increased
on Aug 13, 2010 Female patient from SWEDEN , child 8 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Depocyt (View Usage). Patient had the following side effects: csf pressure increased. Depocyt dosage: 35 Mg;inth. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6955100-9 | Arachnoiditis, Dystonia
Patient was taking Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: arachnoiditis, dystonia (What is dystonia?) on Jul 18, 2008 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with metastases to meninges and. Depocyt dosage: . During the same period patient was treated with ANTIEMETICS AND ANTINAUSEANTS (View Antiemetics And Antinauseants Review and Antiemetics And Antinauseants Label ).

6943346-5 | Bacteroides Infection, Bone Marrow Failure, Neutropenic Infection, Renal Failure
Adverse event was reported on Dec 22, 2008 by a Male patient taking Depocyt (View Usage) (Dosage: 50 Mg; Qd; Inth) was diagnosed with non-hodgkin's lymphoma and. Location: FRANCE , 60 years of age, weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: bacteroides infection, bone marrow failure, neutropenic infection, renal failure. During the same period patient was treated with METHOTREXATE (6000 Mg; Qd; Iv) (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (120 Mg; Qd; Iv) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (1000 Mg; Qd; Iv) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (120 Mg; Qd; Po) (View Prednisone Review and Prednisone Label ), VINCRISTINE (2 Mg; Qd; Iv) (View Vincristine Review and Vincristine Label ), FOLIC ACID (200 Mg; ; Iv) (View Folic Acid Review and Folic Acid Label ), RITUXAN (760 Mg; Qd; Iv) (View Rituxan Review and Rituxan Label ).

6933589-9 | Apraxia, Disorientation
on Aug 03, 2010 Male patient from GERMANY , 67 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient had the following side effects: apraxia, disorientation. Depocyt dosage: 50 Mg;x1;inth. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PANTAZOL (View Pantazol Review and Pantazol Label ), COTRIM (View Cotrim Review and Cotrim Label ), ARA C (View Ara-c Review and Ara-c Label ).

6928919-8 | Asthenia, Blood Pressure Decreased, Cardiomyopathy, Escherichia Sepsis
on Jun 02, 2009 Female patient from FRANCE , 54 years of age, was diagnosed with metastases to meninges, non-hodgkin's lymphoma and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: asthenia, blood pressure decreased, cardiomyopathy (What is cardiomyopathy?), escherichia sepsis. Depocyt dosage: 50 Mg; Inth. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (685 Mg; Iv) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), METHYLPREDNISOLONE (110 Mg;qd;iv) (View Methylprednisolone Review and Methylprednisolone Label ), VINCRISTINE (2 Mg;qd;iv) (View Vincristine Review and Vincristine Label ), METHOTREXATE (5450 Mg;qd;iv) (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (109 Mg;qd;iv) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (450 Mg;bid;iv) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (180 Mg;qd;iv) (View Cytarabine Review and Cytarabine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6916320-2 | Abscess, Sigmoiditis
Patient was taking Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), sigmoiditis on Jul 19, 2010 from FRANCE Additional patient health information: Female patient , 56 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and. Depocyt dosage: 50 Mg; 1x; Inth. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (580 Mg; X1; Iv) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), METHOTREXATE (4600 Mg; X1; Iv) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (2 Mg; X1; Iv) (View Vincristine Review and Vincristine Label ), SOLU MEDROL (240 Mg; Qd; Iv) (View Solu-medrol Review and Solu-medrol Label ), ADRIBLASTINE (DOXORUBICIN HYDROCHLORIDE) (92 Mg; X1; Iv) (View Adriblastine (doxorubicin Hydrochloride) Review and Adriblastine (doxorubicin Hydrochloride) Label ), ENDOXAN /00021101/ (CYCLOPHOSPHAMIDE) (776 Mg; Qd; Iv) (View Endoxan /00021101/ (cyclophosphamide) Review and Endoxan /00021101/ (cyclophosphamide) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6874578-2 | Abscess, Sigmoiditis
Adverse event was reported on Jul 09, 2010 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg;1x;inth) was diagnosed with non-hodgkin's lymphoma and. Location: FRANCE , 56 years of age, weighting 121.3 lb, Patient had the following side effects: abscess (What is abscess?), sigmoiditis. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (580 Mg;x1;iv) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ). Patient was hospitalized.

6857954-3 | Blood Creatinine Increased, Bradycardia, Dysstasia, Encephalopathy, Mental Impairment, Tetany, Urinary Incontinence
on Jun 29, 2010 Female patient from FRANCE , 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: blood creatinine increased, bradycardia, dysstasia, encephalopathy, mental impairment, tetany, urinary incontinence (What is urinary incontinence?). Depocyt dosage: 50 Mg; X 1; Inth. During the same period patient was treated with METHOTREXATE (2 Gm; X 1; Iv; 15 Mg; Qd; Inth) (View Methotrexate Review and Methotrexate Label ), IFOSFAMIDE (3 Gm; Qd;iv) (View Ifosfamide Review and Ifosfamide Label ), NOVANTRONE (20 Mg; Qd; Iv) (View Novantrone Review and Novantrone Label ), ETOPOSIDE (300 Mg; Qd; Iv) (View Etoposide Review and Etoposide Label ), RITUXAN (750 Mg; Qd; Iv) (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

6818701-4 | Cauda Equina Syndrome, Gait Disturbance, Haemorrhage, Myelopathy, Peripheral Motor Neuropathy, Sensory Disturbance, Spinal Disorder
on Jun 17, 2010 Male patient from FRANCE , 69 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: cauda equina syndrome, gait disturbance, haemorrhage, myelopathy, peripheral motor neuropathy, sensory disturbance, spinal disorder. Depocyt dosage: 50 Mg; 1x; Inth. During the same period patient was treated with CORTICOSTEROID (NO PREF. NAME) (View Corticosteroid (no Pref. Name) Review and Corticosteroid (no Pref. Name) Label ).

6786876-1 | Disease Progression, Epilepsy
Patient was taking Depocyt (View Usage). Patient had the following side effects: disease progression, epilepsy (What is epilepsy?) on Jun 10, 2010 from AUSTRIA Additional patient health information: Male patient , 57 years of age, was diagnosed with metastatic neoplasm and. Depocyt dosage: 50 Mg; 1x;inth. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), TOPOTECAN (View Topotecan Review and Topotecan Label ). Patient was hospitalized.

6782807-9 | Blood Creatinine Decreased, Creatinine Renal Clearance Increased, Faecal Incontinence, Muscular Weakness, Oedema Peripheral, Peripheral Motor Neuropathy, Urinary Incontinence
Adverse event was reported on May 31, 2010 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg; 3x; Inth) was diagnosed with central nervous system lymphoma, diffuse large b-cell lymphoma and. Location: GERMANY , 61 years of age, After Depocyt was administered, patient had the following side effects: blood creatinine decreased, creatinine renal clearance increased, faecal incontinence, muscular weakness, oedema peripheral, peripheral motor neuropathy, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with METHOTREXATE (4000 Mg/m**2; ; Iv) (View Methotrexate Review and Methotrexate Label ), IFOSFAMIDE (2000 Mg/m**2; ; Iv) (View Ifosfamide Review and Ifosfamide Label ), DEXAMETHASONE (8 Mg; Po) (View Dexamethasone Review and Dexamethasone Label ), CYTARABINE (3000 Mg/m**2; ; Iv) (View Cytarabine Review and Cytarabine Label ), THIOTEPA (40 ; ; Iv) (View Thiotepa Review and Thiotepa Label ), CARMUSTINE (400 Mg/m**2; 1x; Iv) (View Carmustine Review and Carmustine Label ), ETOPOSIDE (150 Mg/m**2; ; Iv) (View Etoposide Review and Etoposide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized and became disabled.

6750984-1 | Axonal Neuropathy, Balance Disorder, Constipation, Hypoaesthesia, No Therapeutic Response, Paraparesis, Urinary Incontinence
on May 11, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with diffuse large b-cell lymphoma recurrent and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: axonal neuropathy, balance disorder, constipation (What is constipation?), hypoaesthesia, no therapeutic response, paraparesis, urinary incontinence (What is urinary incontinence?). Depocyt dosage: 50 Mg; Inth. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized and became disabled.

6741135-8 |
on May 25, 2010 Male patient from UNITED STATES , 73 years of age, weighting 186.3 lb, was diagnosed with metastatic neoplasm and was treated with Depocyt (View Usage). . Depocyt dosage: 50mg Biweekly Intratracheal. During the same period patient was treated with SORAFENIB 200MG BAYER (400 Mg Twice Daily Po) (View Sorafenib 200mg Bayer Review and Sorafenib 200mg Bayer Label ).

6737559-5 | Breath Sounds Abnormal, Chills, Confusional State, Decubitus Ulcer, Hypophagia, Hypotension, Oedema Peripheral, Oral Candidiasis, Pyrexia
Patient was taking Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: breath sounds abnormal, chills, confusional state, decubitus ulcer, hypophagia, hypotension, oedema peripheral, oral candidiasis, pyrexia on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 186.3 lb, was diagnosed with metastases to meninges and. Depocyt dosage: 50mg Biweekly Intratrache. During the same period patient was treated with SORAFENIB 200MG BAYER (400mg Twice Daily Po) (View Sorafenib 200mg Bayer Review and Sorafenib 200mg Bayer Label ). Patient was hospitalized.

6729955-7 | Arachnoiditis, Fatigue, Headache, Nausea, Radicular Pain, Radiculitis
Adverse event was reported on Apr 28, 2010 by a Male patient taking Depocyt (View Usage) (Dosage: 50 Mg;1x;inth) was diagnosed with metastases to meninges and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: arachnoiditis, fatigue, headache (What is headache?), nausea (What is nausea?), radicular pain, radiculitis. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized and became disabled.

6720966-4 | Epilepsy
on Apr 21, 2010 Male patient from AUSTRIA , 57 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?). Depocyt dosage: 50 Mg; 1x; Inth. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6675086-4 | Hypertonia, Tremor, Unevaluable Event
on Mar 23, 2010 Female patient from SPAIN , child 7 years of age, was diagnosed with burkitt's leukaemia and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: hypertonia, tremor, unevaluable event. Depocyt dosage: Inth. Patient was hospitalized.

6659920-X | Cauda Equina Syndrome, Neurotoxicity
Patient was taking Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: cauda equina syndrome, neurotoxicity on Mar 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, was diagnosed with high grade b-cell lymphoma burkitt-like lymphoma and. Depocyt dosage: 50 Mg; Qm; Inth. Patient was hospitalized and became disabled.

6636045-0 | Cauda Equina Syndrome, Faecal Incontinence, Polyneuropathy, Radicular Syndrome, Urinary Incontinence
Adverse event was reported on Feb 25, 2010 by a Male patient taking Depocyt (View Usage) (Dosage: 50 Mg; 6x; Inth) was diagnosed with chronic lymphocytic leukaemia, metastases to meninges and. Location: GERMANY , 69 years of age, Patient had the following side effects: cauda equina syndrome, faecal incontinence, polyneuropathy, radicular syndrome, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with RITUXIMAB (RITUXIMAB) (5x) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), CYCLOPHOSPHAMIDE (5x) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE PHOSPHATE (5x) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6609439-7 | Breast Cancer Female, Diarrhoea, Malignant Neoplasm Progression, Metastases To Meninges, Sepsis, Skin Ulcer
on Feb 09, 2010 Female patient from GERMANY , 42 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: breast cancer female, diarrhoea, malignant neoplasm progression, metastases to meninges, sepsis (What is sepsis?), skin ulcer. Depocyt dosage: Inth. During the same period patient was treated with TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

6549554-X | Cauda Equina Syndrome, Faecal Incontinence, Polyneuropathy, Radicular Syndrome, Urinary Incontinence
on Jan 04, 2010 Male patient from GERMANY , 69 years of age, was diagnosed with chronic lymphocytic leukaemia, metastases to meninges and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: cauda equina syndrome, faecal incontinence, polyneuropathy, radicular syndrome, urinary incontinence (What is urinary incontinence?). Depocyt dosage: 50 Mg; 6x; Inth. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (5x) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), CYCLOPHOSPHAMIDE (5x) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE PHOSPHATE (5x) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6524682-3 | Cauda Equina Syndrome, Neurotoxicity
Patient was taking Depocyt (View Usage). Patient had the following side effects: cauda equina syndrome, neurotoxicity on Dec 10, 2009 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with chronic lymphocytic leukaemia, metastases to meninges and. Depocyt dosage: 50 Mg, 6-7 X, Inth. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (5x) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), CYCLOPHOSPHAMIDE (5x) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE PHOSPHATE (5x) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ).

6509776-0 | Hyponatraemia, Intracranial Pressure Increased, Loss Of Consciousness, Metastases To Meninges, Syncope, Tonic Convulsion
Adverse event was reported on Dec 21, 2009 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg One Time Intrathecal) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , weighting 183.0 lb, After Depocyt was administered, patient had the following side effects: hyponatraemia, intracranial pressure increased, loss of consciousness, metastases to meninges, syncope, tonic convulsion. During the same period patient was treated with SOLU CORTEF (2.5 Mg One Time Intrathecal) (View Solu-cortef Review and Solu-cortef Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DOCUSATE (View Docusate Review and Docusate Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6493707-6 | Brain Oedema, Cerebral Infarction, Loss Of Consciousness, Neurotoxicity
on Nov 27, 2009 Male patient from GERMANY , 58 years of age, was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, cerebral infarction, loss of consciousness, neurotoxicity. Depocyt dosage: 50 Mg;5x;inth. During the same period patient was treated with METHOTREXATE (1650 Mg;1x;ivdrp) (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6454734-8 | Atrial Fibrillation, Back Pain, Bradycardia, Headache, Hypotension, Nausea, Post Lumbar Puncture Syndrome, Pyrexia
on Nov 04, 2009 Female patient from POLAND , 18 years of age, was treated with Depocyt (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), bradycardia, headache (What is headache?), hypotension, nausea (What is nausea?), post lumbar puncture syndrome, pyrexia. Depocyt dosage: 50 Mg; Inth. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ). Patient was hospitalized.

6419565-3 | Blood Pressure Decreased, Diarrhoea, Flushing, Headache, Hypersensitivity, Nausea
Patient was taking Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: blood pressure decreased, diarrhoea, flushing, headache (What is headache?), hypersensitivity, nausea (What is nausea?) on Oct 13, 2009 from GERMANY Additional patient health information: Male patient , child 11 years of age, weighting 74.96 lb, was diagnosed with meningioma malignant and. Depocyt dosage: 35 Mg; 1x; Itvn. During the same period patient was treated with SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6381585-5 | Atrial Fibrillation, Bradycardia, Disease Progression, Headache, Hypotension, Intracranial Hypotension, Nausea, Post Lumbar Puncture Syndrome, Pyrexia
Adverse event was reported on Sep 11, 2009 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg;inth) . Location: POLAND , 18 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, disease progression, headache (What is headache?), hypotension, intracranial hypotension, nausea (What is nausea?), post lumbar puncture syndrome, pyrexia. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6380685-3 | Coma, Electroencephalogram Abnormal, Encephalopathy, Grand Mal Convulsion, Neurotoxicity, Nuclear Magnetic Resonance Imaging Abnormal, Overdose
on Sep 09, 2009 Male patient from POLAND , 14 years of age, weighting 101.4 lb, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient had the following side effects: coma, electroencephalogram abnormal, encephalopathy, grand mal convulsion, neurotoxicity, nuclear magnetic resonance imaging abnormal, overdose. Depocyt dosage: 50 Mg;x4;inth. During the same period patient was treated with IDARUBICIN HCL (30;1x) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), FLUDARABINE PHOSPHATE (48 Mg;qd;po) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTARABINE (30 Mg;qx;inth) (View Cytarabine Review and Cytarabine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6375947-X | Cauda Equina Syndrome
on Sep 03, 2009 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: cauda equina syndrome. Depocyt dosage: 50 Mg; Inth.

6375945-6 | Post Lumbar Puncture Syndrome
Patient was taking Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: post lumbar puncture syndrome on Sep 03, 2009 from POLAND Additional patient health information: Female patient , 18 years of age, . Depocyt dosage: 50 Mg. Patient was hospitalized.

6372130-9 | Leukopenia, Neutropenia
Adverse event was reported on Sep 02, 2009 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg; X3; Inth) was diagnosed with metastases to meninges and. Location: AUSTRIA , 59 years of age, Patient had the following side effects: leukopenia, neutropenia. During the same period patient was treated with METAMIZOLE (METAMIZOLE) (View Metamizole (metamizole) Review and Metamizole (metamizole) Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROMORPHONE HYDROCHLORIDE (View Hydromorphone Hydrochloride Review and Hydromorphone Hydrochloride Label ), .. (View .. Review and .. Label ), DEXIBUPROFEN (View Dexibuprofen Review and Dexibuprofen Label ). Patient was hospitalized.

6369320-8 | Central Nervous System Lesion, Encephalopathy, Grand Mal Convulsion
on Sep 02, 2009 Male patient from POLAND , 14 years of age, weighting 101.4 lb, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: central nervous system lesion, encephalopathy, grand mal convulsion. Depocyt dosage: 50 Mg;x4;inth. During the same period patient was treated with IDARUBICIN HCL (30;1x) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), FLUDARABINE PHOSPHATE (48 Mg;qd;po) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTARABINE (30 Mg;1x;inth) (View Cytarabine Review and Cytarabine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DEXAMETHASONE 4MG TAB (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6340254-8 | Acute Myeloid Leukaemia, Central Nervous System Lesion, Coma, Disease Progression, Encephalopathy, Neurotoxicity, Overdose
on Aug 19, 2009 Male patient from POLAND , 14 years of age, weighting 101.4 lb, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, central nervous system lesion, coma, disease progression, encephalopathy, neurotoxicity, overdose. Depocyt dosage: 50 M; X4; Inth. During the same period patient was treated with IDARUBICIN (IDABURICIN) (19.2 MG) (30; 1x) (View Idarubicin (idaburicin) (19.2 Mg) Review and Idarubicin (idaburicin) (19.2 Mg) Label ), FLUDARABINE PHOSPHATE (48 Mg; Qd; Po) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTARABINE (30 Mg; 1x; Inth) (View Cytarabine Review and Cytarabine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6318685-1 | Aplasia, Bacterial Sepsis, Bone Marrow Failure, Enterobacter Sepsis, Meningitis, Systemic Inflammatory Response Syndrome
Patient was taking Depocyt (View Usage). Patient had the following side effects: aplasia, bacterial sepsis, bone marrow failure, enterobacter sepsis, meningitis (What is meningitis?), systemic inflammatory response syndrome on Aug 04, 2009 from BELGIUM Additional patient health information: Male patient , 55 years of age, weighting 176.4 lb, was diagnosed with metastases to meninges and. Depocyt dosage: 50 Mg, 1x, Inth. During the same period patient was treated with VINCRISTINE (2 Mg; Qd; Iv) (View Vincristine Review and Vincristine Label ), METHOTREXATE (5500 Mg, Qd; Iv) (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (110 Mg, Qd; Iv) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (460 Mg, Qd; Iv) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6315575-5 | Central Nervous System Lesion, Electroencephalogram Abnormal, Encephalopathy, Grand Mal Convulsion
Adverse event was reported on Aug 04, 2009 by a Male patient taking Depocyt (View Usage) (Dosage: 50 Mg; ; Inth) was diagnosed with metastases to meninges and. Location: POLAND , 14 years of age, weighting 101.4 lb, After Depocyt was administered, patient had the following side effects: central nervous system lesion, electroencephalogram abnormal, encephalopathy, grand mal convulsion. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ).

6305358-4 | Brain Oedema, Cerebral Infarction, Loss Of Consciousness, Neurotoxicity
on Jul 22, 2009 Male patient from GERMANY , 58 years of age, was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, cerebral infarction, loss of consciousness, neurotoxicity. Depocyt dosage: 50 Mg; X2; Inth. During the same period patient was treated with METHOTREXATE (1650 Mg; 1x; Ivdrp) (View Methotrexate Review and Methotrexate Label ), METOTREXATE (View Metotrexate Review and Metotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6304538-1 | Coma, Deafness, Epilepsy, Facial Paresis, Sopor
on Jul 23, 2009 Female patient from AUSTRIA , 52 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient had the following side effects: coma, deafness, epilepsy (What is epilepsy?), facial paresis, sopor. Depocyt dosage: 50 Mg;unk;inth. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

6304521-6 | Bacterial Sepsis
Patient was taking Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: bacterial sepsis on Jul 22, 2009 from BELGIUM Additional patient health information: Male patient , 55 years of age, weighting 176.4 lb, was diagnosed with metastases to meninges and. Depocyt dosage: 50 Mg;1x;inth. During the same period patient was treated with VINCRISTINE (2 Mg;qd;iv) (View Vincristine Review and Vincristine Label ), METHOTREXATE (5500 Mg;qd;iv) (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (110 Mg;qd;iv) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (460 Mg;qd;iv) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6274648-6 | Bone Marrow Failure, Catheter Related Infection, Headache, Leukopenia, Thrombocytopenia
Adverse event was reported on Jul 02, 2009 by a Male patient taking Depocyt (View Usage) (Dosage: 50 Mg; X2; Inth) was diagnosed with metastases to central nervous system and. Location: UNITED STATES , 43 years of age, Patient experienced the following unwanted or unexpected effects: bone marrow failure, catheter related infection, headache (What is headache?), leukopenia, thrombocytopenia.

6274647-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Balance Disorder, Bone Marrow Failure, Fall, Headache, Leukopenia, Malaise
on Jul 10, 2009 Female patient from UNITED STATES , 53 years of age, was diagnosed with metastases to meninges and was treated with Depocyt (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, balance disorder, bone marrow failure, fall (What is fall?), headache (What is headache?), leukopenia, malaise. Depocyt dosage: 50 Mg'; 1x; Inth. During the same period patient was treated with ONDANSETRON (CON.) (View Ondansetron (con.) Review and Ondansetron (con.) Label ). Patient was hospitalized.

6255503-4 | Back Pain, Central Line Infection, Crepitations, Depression, Sepsis, Staphylococcal Infection, Thrombocytopenia
on Jun 15, 2009 Female patient from FRANCE , 56 years of age, weighting 187.4 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: back pain (What is back pain?), central line infection, crepitations, depression (What is depression?), sepsis (What is sepsis?), staphylococcal infection (What is staphylococcal infection?), thrombocytopenia. Depocyt dosage: 50 Mg;qd; Inth. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6235617-5 | Altered State Of Consciousness, Encephalopathy, Headache, Hernia, Inflammation, Post Procedural Complication
Patient was taking Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, encephalopathy, headache (What is headache?), hernia (What is hernia?), inflammation, post procedural complication on Jun 03, 2009 from FRANCE Additional patient health information: Female patient , 49 years of age, was diagnosed with metastases to meninges and. Depocyt dosage: 50 Mg; 1x; Inth.

6202927-7 | Leukoencephalopathy
Adverse event was reported on Jan 13, 2009 by a Female patient taking Depocyt (View Usage) (Dosage: 50 Mg; X2; Inth) was diagnosed with metastases to meninges and. Location: GERMANY , 40 years of age, weighting 132.3 lb, Patient had the following side effects: leukoencephalopathy. During the same period patient was treated with METHOTREXATE (15 Mg; X4; Inth) (View Methotrexate Review and Methotrexate Label ).

6187693-6 | Abnormal Behaviour, Altered State Of Consciousness, Disease Progression, Dissociative Disorder, Infection, Medulloblastoma, Memory Impairment, Metastatic Neoplasm, Regressive Behaviour
on May 06, 2008 Female patient from POLAND , 15 years of age, was diagnosed with medulloblastoma and was treated with Depocyt (View Usage). After Depocyt was administered, patient had the following side effects: abnormal behaviour, altered state of consciousness, disease progression, dissociative disorder, infection (What is infection?), medulloblastoma, memory impairment, metastatic neoplasm, regressive behaviour. Depocyt dosage: 50 Mg; Qow; Inth. During the same period patient was treated with DEXAVEN (View Dexaven Review and Dexaven Label ), BISEPTOL (View Biseptol Review and Biseptol Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), TRAZOL (View Trazol Review and Trazol Label ), ZOFRAN (View Zofran Review and Zofran Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ). Patient was hospitalized.

6158899-7 | Constipation, Peripheral Sensory Neuropathy, Renal Failure Acute, Urinary Retention
on Mar 26, 2009 Female patient from GERMANY , 65 years of age, weighting 119.0 lb, was diagnosed with central nervous system leukaemia and was treated with Depocyt (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), peripheral sensory neuropathy, renal failure acute, urinary retention. Depocyt dosage: 50 Mg; X2; Inth. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TRIMETHOPRIM SULFAMETHOXAZOLE (View Trimethoprim-sulfamethoxazole Review and Trimethoprim-sulfamethoxazole Label ).

6144589-3 | Anal Sphincter Atony, Disease Progression, Faecal Incontinence, Hypoaesthesia, Lymphoma, Neurotoxicity
Patient was taking Depocyt (View Usage). Patient had the following side effects: anal sphincter atony, disease progression, faecal incontinence, hypoaesthesia, lymphoma (What is lymphoma?), neurotoxicity on Mar 19, 2009 from SWITZERLAND Additional patient health information: Female patient , 73 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Depocyt dosage: 50 Mg; Inth. During the same period patient was treated with CYCLOPHOSPHAMIDE (CON.) (View Cyclophosphamide (con.) Review and Cyclophosphamide (con.) Label ), VINCRISTINE (CON.) (View Vincristine (con.) Review and Vincristine (con.) Label ), DOXORUBICIN (CON.) (View Doxorubicin (con.) Review and Doxorubicin (con.) Label ), PREDNISONE (CON.) (View Prednisone (con.) Review and Prednisone (con.) Label ).